| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |